Company Profile for Acucela Inc.
–(BUSINESS WIRE)–Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwid…
Alcon Offers BAK-Free Formula Eye Drops
A new formulation of Travatan (40 micrograms/ml eye drops, solution travoprost) has been launched by Alcon Laboratories. It is aimed at addressing the irritation and inflammation some glaucoma patients can experience with preservatives.
New Year, New Vision, New Health
VISTAKON®, Division of Johnson & Johnson Vision Care, Inc., and makers of ACUVUE® Brand Contact Lenses announced the “New You” sweepstakes to give consumers the chance to have improved vision and better fitness in the New Year. Sixty-three percent of…
U.S. Department Of Defense Supports Study Of Brain, Eye Injuries In Military Personnel
The Virginia Tech-Wake Forest University Center for Injury Biomechanics has been awarded a $2.8 million contract from the U.S. Army Medical Research and Materiel Command for phase 2 of an overall project focusing on brain and eye injuries in military p…
Scientific Evidence Supports Effectiveness Of Chinese Drug For Cataracts
Scientists are reporting a scientific basis for the long-standing belief that a widely used non-prescription drug in China and certain other countries can prevent and treat cataracts, a clouding of the lens of the eye that is a leading cause of vision…